Masteron Runners Athletes Using Steroids Oral Pharma Raw Materials EINECS 208-303-1

Masteron Runners Athletes Using Steroids Oral Pharma Raw Materials EINECS 208-303-1

Synonyms: Masteron; Dromostanolone Propionate
CAS: 521-12-0
EINECS: 208-303-1
Molecular formula: C23H36O3
Molecular weight: 360.53
Assay: 99%
Packing: Foil bag or tin.
Delivery: Express courier.
Character: White crystalline powder.
Min. order quantity: 10g
Usage: Pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones.

Description of Drostanolone propionate:
Drostanolone propionateis an ester of drostanolone. Drostanolone is indicated in post menopausal women with recurrent breast cancer, in combined hormone therapy.Drostanolone causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism.

The antitumor activity of drostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.

Masteron 100 USP injection provides drostanolone propionate, a potent androgenic steroid that has similar characterises of dihydrotestosterone. Drostanolone is incapable of aromization and therefore doesn't convert into oestrogen. Both drostanolone' anabolic and androgenic activity is far greater than methyl testosterone. The esterification of the 17-beta-hydroxyl group increases the duration of the action of drostanolone. Drostanolone esters in oil injected intramuscularly are absorbed slowly from the lipid phase, thus Masterone 100 can be administered at intervals of every 3-4 days.

Application of Drostanolone propionate:
Steroids Hormone Drostanolone propionate / Masteron/Drostanolone/Drolban/CAS No: 521-12-0 Masteron is often an ideal choice for inclusion in a steroid stack, or in some cases for use as the sole injectable for a steroid cycle. An enanthate ester version having a half-life of probably 5 days has become available. This version of Masteron may be injected as infrequently as twice per week.

Test Report: